Ridaforolimus (also known as AP23573 and MK-8669; formerly known as Deforolimus) is an investigational targeted and small-molecule inhibitor of the protein mTOR a protein that acts as a central regulator of protein synthesis cell proliferation cell cycle progression and cell survival integrating signals from proteins such as PI3K AKT and PTEN known to be important to malignancy.
This page contains content from the copyrighted Wikipedia article "Ridaforolimus"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
